15 | ̿ | Impact of integrating genomic data into the electronic health record on genetics care delivery | J.Club |
14 | ̿ | Splitting overlapped region between amplicons method to detect somatic copy number variation (CNV) with PCR-based targeted sequencing | TopicSem |
28 | ̿ | The Prognostic Potential of Allele Specific Loss of Heterozygosity in TNBC | TopicSem |
14 | ̿ | Aggregate Trend of LOH by eQTL method | MAInfo |
18 | ̿ | Synthetic lethality mediated precision oncology via the tumor transcriptome | J.Club | |
27 | ̿ | Prognostic Potential of Loss of Heterozygosityin Triple Negative Breast Cancer | TopicSem |
09 | ̿ | AlphaFold : Highly Accurate Protein Structure Prediction | MAInfo | |
26 | ̿ | Prognostic Potential of Loss of Heterozygosity in TNBC | TopicSem |
22 | ̿ | Prognostic Potential of Loss of Heterozygosity in Triple Negative Breast Cancer | TopicSem | |
31 | ̿ | The tumor therapy landscape of synthetic lethality | J.Club |
14 | ̿ | Systemic Discovery Prognostic Potential Loss of Heterozygosity IL9 Expression Analysis | TopicSem | |
21 | ̿ | GTEX eQTL data | MAInfo |
03 | ̿ | Systemic Discovery Prognostic Potential Loss of Heterozygosity | TopicSem | |
22 | ̿ | Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy | J.Club |
06 | ̿ | Comprehensive Analysis of Genetic Ancestry and ItsMolecular Correlates in Cancer | J.Club | |
18 | ̿ | Korean TNBC Kinome Data Analysis | TopicSem |
04 | ̿ | Korean TNBC Kinome Analysis | TopicSem | |
21 | ̿ | Korean TNBC Kinome data Survival Analysis | TopicSem | |
28 | ̿ | TNBC Survival Analysis | MAInfo |
05 | ̿ | Korean TNBC Kinome Analysis | TopicSem | |
29 | ̿ | Triple Negative Breast Cancer Genome Analysis | TopicSem |
10 | ̿ | Korean Uveal Melanoma Analysis | TopicSem | |
10 | ̿ | NGS CheckMate : Validating sample identity in NGS studies | xMutant | |
27 | ̿ | CNV Validation Candidate Selection | MAInfo |
04 | ̿ | Uveal Melanoma Analysis: Somatic Mutation | MAInfo | |
11 | ̿ | Analysis of Uveal Melanoma Genome | TopicSem |
14 | ̿ | Genome Analysis of Uveal Melanoma | TopicSem | |
25 | ̿ | Uveal melanoma germline analysis | xMutant |
05 | ̿ | PRISM Drug Repurposing Resource | xMutant | |
12 | ̿ | Access and Download the EGA European Genome-Phenome Archive | MAInfo | |
23 | ̿ | Genome Analysis of Asian Uveal Melanoma | TopicSem |
22 | ̿ | Discovering the anticancer potential of nononcology drugs by systematic viability profiling | J.Club | |
27 | ̿ | TopicSem |
07 | ̿ | Copy Number Alteration Algorithms for Amplicon-based Targeted Sequencing Panel data | TopicSem | |
21 | ̿ | Visualization of Copy Number Variation | xMutant |
12 | ̿ | How good are pathogenicity predictors in detecting benign variants? | J.Club | |
17 | ̿ | Performance Comparison of Ampicon Based Sequencing Conpy Number Detection Tools | MAInfo |
23 | ̿ | Copy number detection in amplicon based targeted sequencing | TopicSem | |
26 | ̿ | GDC Tumor Only Variant Calling Pipeline with Uveal Melanoma | xMutant |
05 | ̿ | Prognostic Potential Loss of Heterozygosityin TNBC | TopicSem | |
17 | ̿ | A longtudinal big data approach for precision health | J.Club |
11 | ̿ | The Progsotic Potential of Loss of Heterozygosity | MAInfo | |
12 | ̿ | Copy Number Variation Algorithm | xMutant | |
18 | ̿ | The Progsotic Potential of Loss of Heterozygosity | TopicSem |
09 | ̿ | Re-identification of individuals in genomic data-sharing beacons via allele inference | J.Club | |
14 | ̿ | Inhouse CNV Algorithm | TopicSem |
20 | ̿ | The Progsotic Potential of Loss of Heterozygosity in Breast Invasive Carcinoma | TopicSem | |
26 | ̿ | The Progsotic Potential of Loss of Heterozygosity in Breast Invasive Carcinoma | Seminar |
03 | ̿ | The chromatin accessibility landscape of primary human cancers | J.Club | |
19 | ̿ | Analysis of LOH Affecting Breast Cancer Survival | TopicSem | |
27 | ̿ | PEPTATAC : A robust ATAC-seq pipeline | xMutant |
01 | ̿ | Evaluation of in silico algorithms for use with ACMG/AMP clinical variant interpretation guidelines | J.Club | |
10 | ̿ | Analysis of LOH Affecting Cancer Survival | TopicSem |
02 | ̿ | Analysis of LOH Affecting Cancer Survival | TopicSem | |
07 | ̿ | Preprocessing Pipelines of PacBio and Nanopore Sequencing Data | xMutant |
09 | ̿ | Survival Analysis- Cox Proportional Hazard of TNBC Analysis | TopicSem | |
09 | ̿ | Copy Number Alteration Visualization | MAInfo |
21 | ̿ | Clinical Feature Selection for Cox Proportional-Hazards Mode in SNUH TNBC Analysis | MAInfo |
01 | ̿ | The Prognostic Potential of Loss of Heterozygosity in Breast Invasive Carcinoma | TopicSem | |
22 | ̿ | Cochle araplasia trio family analysis | xMutant |
01 | ̿ | The Prognostic Potential of Loss of Heterozygosity in Breast Invasive Carcinoma | TopicSem | |
11 | ̿ | Overexpressed Somatic Alleles are Enriched in Functional Elements in Breast Cancer | J.Club |
25 | ̿ | Somatic Mutation Analysis with WGS of Small Round Cell Tumor in Brain | MAInfo | |
26 | ̿ | Comparison of Adapter Trimmers for Illumina Miseq Data | xMutant |
18 | ̿ | CNV analysis of Cancer Panel 2.0 Data | TopicSem |
05 | ̿ | Comparison Results of vcf Normalization | xMutant | |
12 | ̿ | Loss of Heterozygosity Analysis in Breast Invasive Carcinoma | TopicSem |
01 | ̿ | The Prognostic Potential of Loss of Heterozygosity in Breast Invasive Carcinoma | TopicSem | |
03 | ̿ | Improved VCF Nomralization | xMutant |
15 | ̿ | Fast, scalable prediction of deleterious noncoding variants from functional and population genomic data | J.Club | |
26 | ̿ | How to get controlled access data from ICGC data portal. | MAInfo |
04 | ̿ | Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown. | MAInfo | |
18 | ̿ | Survival analysis of Loss of Heterozygosity in triple-negative breast cancer | xMutant |
28 | ̿ | The prognostic potential of loss of heterozygosity in breast invasive carcinoma | TopicSem |
12 | ̿ | Loss of heterozygosity as prognostic marker in Breast invasive carcinoma | TopicSem |
13 | ̿ | L.O.H Analysis on 5 Cancer types data from TCGA | TopicSem | |
20 | ̿ | Review and Practice of HISAT 2 pipeline | MAInfo |
04 | ̿ | LOH Analysis - Validation DP filtering with Sanger sequencing data | TopicSem |
11 | ̿ | SCF- A Standard file format for data from DNA sequencing instruments | xMutant | |
15 | ̿ | TCGA multicenter calling problem and Validation DP filter | MAInfo |
08 | ̿ | Package for analysing cancer panel data | xMutant | |
09 | ̿ | Prgress of Cancer panel and Loss of heterozygosity analysis | TopicSem |
04 | ̿ | Review: SpeedSeq - ultra fast personal genome analysis and interpretation | xMutant | |
18 | ̿ | Review ClinSeK: a targeted variant characterization framework for clinical sequencing | MAInfo |
01 | ̿ | Reversal loss of heterozygosity in UCEC | TopicSem | |
24 | ̿ | Kataegis and Rainfall plot | MAInfo | |
24 | ̿ | Kataegis and Rainfall plot | MAInfo | |
31 | ̿ | Kataegis and Rainfall plot for TCGA data | xMutant |
01 | ̿ | Brief Summary of RAL and Reversal LOH | TopicSem | |
26 | ̿ | Statistical reulst of TCGA protected vcf files | xMutant |
10 | ̿ | Review of public genome data: TCGA Lv2 VCF data & 1000Genome phase3 | MAInfo | |
29 | ̿ | LOH(Loss of Heterozygosity) Analysis | TopicSem |
14 | ̿ | DNA methylation age of human tissues and cell types | J.Club | |
25 | ̿ | Result of Genome wide Analysis of non-coding region in cancer and Plan for methylation profile | TopicSem |
11 | ̿ | Replication : Genome wide Analysis of non-coding regulatory mutations in cancer | TopicSem |
07 | ̿ | non-coding region analysis with replication time data | TopicSem | |
16 | ̿ | Review of MutSig | MAInfo | |
26 | ̿ | SG11 | Seminar |
05 | ̿ | Personal Genome Interpretation | Seminar | |
21 | ̿ | Process of non-coding region analysis | MAInfo |
24 | ̿ | Thyroid data analysis using cluster method and different gene set | TopicSem |
09 | ̿ | Replication of Reactive Oxygen Species Related Gene Expression differences between Thyroid carcinoma with & with out Hashimoto Thyroiditis&Normal | TopicSem | |
11 | ̿ | G.S.E.A for data analysis | MAInfo |
07 | ̿ | Replication of Synthetic lethality and further research in Ovarian Serous Cystadenocarcinoma | TopicSem | |
29 | ̿ | TCGA ovarian cancer patient data analysis | MAInfo | |
29 | ̿ | TCGA ovarian cancer patient data analysis | MAInfo |
24 | ̿ | Network based survival | MAInfo |
05 | ̿ | TCGA data preview | MAInfo | |
20 | ̿ | NEJM_2009_Molecular origins of cancer :DNA Damage, Aging and cancer | MAInfo | |
27 | ̿ | nature_Comprehensive molecular portraits of human breast tumour | MAInfo |